GlassScriptPhysician profile
Natalie Crouse
NPI 1144621970
$14,405.63
in general payments reported to CMS, 2019-2025
6 companies · $976 in 2025
The $976 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,116 · 2022: $6,808 · 2023: $2,325 · 2024: $180 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,382 · Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,381.98 |
| Food and Beverage | $1,099.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13,112.44 | 2021-2025 | Nexplanon |
| Gilead Sciences, INC. | $701.83 | 2021-2025 | Yeztugo, Descovy |
| Revance Therapeutics, INC. | $376.16 | 2025 | Daxxify |
| Viiv Healthcare Company | $148.73 | 2025 | Apretude |
| Merck Sharp & Dohme LLC | $42.27 | 2021-2022 | |
| Medicines360 | $24.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Crouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.